Cost-effectiveness of alternative smoking cessation scenarios in Spain: results from the EQUIPTMOD

Cost effectiveness analysis of smoking cessation interventions.

OBJECTIVE To identify which smoking cessation interventions provide the most efficient use of health care resources at a population level. METHODS Effectiveness data were obtained from a review of the international literature. Costs and effects of smoking cessation interventions were estimated from the perspective of the Australian Government. Treatment costs and effects were modelled using i...

Cost-effectiveness of pharmacotherapy for smoking cessation

Cost-effectiveness analysis, even with its inherent methodological problems, consistently shows that when smoking cessation interventions are effective they are invariably also cost-effective. This is largely due to their relative low cost and the big impact that stopping smoking has on health outcomes. This is also the case for pharmacotherapy for smoking cessation, including nicotine replacem...

Cost-effectiveness of varenicline compared with nicotine patches for smoking cessation--results from four European countries.

BACKGROUND The aim of this study was to evaluate and compare the cost-effectiveness of varenicline with nicotine replacement therapy (NRT) for smoking cessation in four European countries (Belgium, France, Sweden and the UK). METHODS Markov simulations, using the Benefits of Smoking Cessation on Outcomes (BENESCO) model, were performed. We simulated the incidence of four smoking-related morbi...

Cost-effectiveness of smoking cessation and the implications for COPD

The cost burden of COPD is substantial for patients and families, payers, and society as a whole. Smoking has been known for decades to be the leading cause of the disease. Numerous studies have been completed to address the cost-effectiveness of programs created to aid smokers in their efforts to quit. Because several assumptions must be made in order to conduct such a study, and because diffe...

Cost-effectiveness of financial incentives for smoking cessation in pregnancy.